1. Zhao, Yichao, Tabet, Daniel, Rubio Contreras, Diana, Roth, Frederick P, Durocher, Daniel. 2023. Genome-scale mapping of DNA damage suppressors through phenotypic CRISPR-Cas9 screens. In Molecular cell, 83, 2792-2809.e9. doi:10.1016/j.molcel.2023.06.025. https://pubmed.ncbi.nlm.nih.gov/37478847/
2. Ishiguro, Hiroki, Koga, Minori, Horiuchi, Yasue, Nawa, Hiroyuki, Arinami, Tadao. 2008. Supportive evidence for reduced expression of GNB1L in schizophrenia. In Schizophrenia bulletin, 36, 756-65. doi:10.1093/schbul/sbn160. https://pubmed.ncbi.nlm.nih.gov/19011233/
3. Chen, Ying-Zhang, Matsushita, Mark, Girirajan, Santhosh, Raskind, Wendy H, Brkanac, Zoran. 2011. Evidence for involvement of GNB1L in autism. In American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 159B, 61-71. doi:10.1002/ajmg.b.32002. https://pubmed.ncbi.nlm.nih.gov/22095694/
4. Nalesnik, Michael A, Tseng, George, Ding, Ying, Michalopoulos, George K, Luo, Jian-Hua. 2012. Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation. In The American journal of pathology, 180, 1495-508. doi:10.1016/j.ajpath.2011.12.021. https://pubmed.ncbi.nlm.nih.gov/22326833/